1
|
Piña-Olmos S, Dolores-Hernández M, Diaz-Torres R, Ramírez-Bribiesca JE, López-Arellano R, López Barrera LD, Ramírez-Noguera P. Precision-cut liver slices as a model for assess hepatic cellular response of chitosan-glutathione nanoparticles on cultures treated with zilpaterol and clenbuterol. Toxicol Mech Methods 2021; 32:313-324. [PMID: 34747310 DOI: 10.1080/15376516.2021.2002992] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
Zilpaterol and clenbuterol are two β-adrenergic agonist drugs used in animal production. Both drugs have anabolic effects with advantages on carcass yield. Meanwhile, zilpaterol is approved for animal feed in authorized countries. Clenbuterol is a banned substance due to the risk of toxicity; however, it is still being used in unknown dose levels in many farm species. Therefore, the use and abuse of these substances should be closely monitored, considering the clenbuterol ability and the not proved yet of zilpaterol to produce reactive oxygen and nitrogen species. Regarding glutathione which is the main intracellular antioxidant plays detoxification functions on liver metabolism; in this work, it is our interest to know the capacity of chitosan-glutathione nanoparticles (CS/GSH-NP) as a complementary source of exogenous GSH to modify the oxide-reduction status on bovine precision-cut liver slice cultures (PCLS) exposed to clenbuterol and zilpaterol. A single drug assay was performed in first instance by adding clenbuterol, zilpaterol, chitosan nanoparticles (CS-NP), and CS/GSH-NP. Then combinate drug assay was carried out by testing clenbuterol and zilpaterol combined with CS-NP or CS/GSH-NP. The results showed that both β-adrenergic agonists modify in a dose-dependent manner in oxide-reduction response through ROS generation. The activity or content of glutathione peroxidase activity, intracellular GSH, gamma glutamyl-transpeptidase, aspartate aminotrasnferase and alanine aminotrasnferase were modified. The exogenous GSH delivered by nanoparticles could be used to modulate these markers.
Collapse
Affiliation(s)
- Sofia Piña-Olmos
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Mariana Dolores-Hernández
- Laboratorio de Desarrollo Farmacéutico (LEDEFAR), Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Roberto Diaz-Torres
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - J Efrén Ramírez-Bribiesca
- Programa de Ganadería, Colegio de Posgraduados, Montecillo, Carretera México-Texcoco Km 36.5, Montecillo, Estado de México, México
| | - Raquel López-Arellano
- Laboratorio de Desarrollo Farmacéutico (LEDEFAR), Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Laura Denise López Barrera
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| | - Patricia Ramírez-Noguera
- Laboratorio de Toxicología Celular L-9, Unidad de Investigación Multidisciplinaria, FES-Cuautitlán, Campo 4, Carretera México-Teoloyucan Km 2.5, San Sebastián Xhala, Cuautitlán Izcalli Estado de México, México
| |
Collapse
|
2
|
Al-Majed AA, Khalil NY, Khbrani I, Abdel-Aziz HA. Clenbuterol Hydrochloride. PROFILES OF DRUG SUBSTANCES, EXCIPIENTS, AND RELATED METHODOLOGY 2017; 42:91-123. [PMID: 28431781 DOI: 10.1016/bs.podrm.2017.02.002] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Clenbuterol (Broncodil and trade) is a direct-acting sympathomimetic agent with mainly beta-adrenergic activity and a selective action on β2 receptors (a β2 agonist). It has properties similar to those of salbutamol. It is used as a bronchodilator in the management of reversible airways obstruction, as in asthma and in certain patients with chronic obstructive pulmonary disease. The uses, applications, and the synthetic pathways of this drug are outlined. Physical characteristics including: ionization constant, solubility, X-ray powder diffraction pattern, thermal methods of analysis, UV spectrum, IR spectrum, mass spectrum are all produced. This profile also includes the monograph of British Pharmacopoeia, together with several reported analytical methods including spectrophotometric, electrochemical, chromatographic, immunochemical methods, and capillary electrophoretic methods. The stability, the pharmacokinetic behavior, and the pharmacology of the drug are also provided.
Collapse
Affiliation(s)
| | - Nasr Y Khalil
- College of Pharmacy, King Saud University, Riyadh, Saudi Arabia
| | | | | |
Collapse
|
3
|
GU X, LIU YM, YAO T, SHI HL, LI J, ZHAO Z, QIN YC. Identification of Major Metabolites of Salbutamol in Swine Urine and Plasma Using Ultra-High Performance Liquid Chromatography-Electrospray Time of Flight Mass Spectrometry. CHINESE JOURNAL OF ANALYTICAL CHEMISTRY 2014. [DOI: 10.1016/s1872-2040(14)60784-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
4
|
Domínguez-Romero JC, García-Reyes JF, Martínez-Romero R, Martínez-Lara E, Del Moral-Leal ML, Molina-Díaz A. Detection of main urinary metabolites of β2-agonists clenbuterol, salbutamol and terbutaline by liquid chromatography high resolution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2013; 923-924:128-35. [PMID: 23500357 DOI: 10.1016/j.jchromb.2013.02.008] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2012] [Revised: 01/31/2013] [Accepted: 02/06/2013] [Indexed: 10/27/2022]
Abstract
Clenbuterol, terbutaline and salbutamol are B2-agonists drugs included in the list of banned substances of the World Anti Doping Agency (WADA) prohibited in and out of competition. In this article, the excretion of urinary metabolites of clenbuterol, terbutaline and salbutamol have been studied using liquid chromatography electrospray time-of-flight mass spectrometry (LC-TOFMS), after a single therapeutic dose administration in rats. Urine collected was processed with solid-phase extraction prior to LC-TOFMS analyses using electrospray in the positive ion mode and pseudo MS/MS experiments from in-source collision induced dissociation (CID) fragmentation (without precursor ion isolation). The strategy applied for the identification of metabolites was based on the search of typical biotransformations with their corresponding accurate mass shift and the use of common diagnostic fragment ions from the parent drugs. The approach was satisfactory applied, achieving the identification of 11 metabolites (5 from clenbuterol, 4 from salbutamol and 3 from terbutaline), 4 of them not previously reported in urine. Novel metabolites identified in rat urine included N-oxide-salbutamol, hydroxy-salbutamol, methoxy-salbutamol glucuronide and terbutaline N-oxide, which are all reported here for the first time.
Collapse
|
5
|
Li K, Qin F, Jing L, Li F, Guo X. In vivo and in vitro metabolism of a novel β2-adrenoceptor agonist, trantinterol: metabolites isolation and identification by LC-MS/MS and NMR. Anal Bioanal Chem 2013; 405:2619-34. [PMID: 23338754 DOI: 10.1007/s00216-012-6652-9] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2012] [Revised: 12/05/2012] [Accepted: 12/10/2012] [Indexed: 01/14/2023]
Abstract
Trantinterol is a novel β(2)-adrenoceptor agonist used for the treatment of asthma. The aim of this study is to identify the metabolites of trantinterol using liquid chromatography tandem mass spectrometry (LC-MS/MS), to isolate the main metabolites, and confirm their structures by nuclear magnetic resonance (NMR). Urine, feces, bile, and blood samples of rats were obtained and analyzed. Reference standards of six metabolites were achieved with the combination of chemical synthesis, microbial transformation, and the model systems of rats. Moreover, in order to investigate the phase I metabolism of trantinterol in humans and to study the species differences between rats and humans, incubations with liver microsomes were performed. The biotransformation by a microbial model Cunninghamella blakesleana AS 3.970 was also studied. A total of 18 metabolites were identified in vivo and in vitro together, 13 of which were newly detected. Three phase I metabolites were detected in vivo and in vitro as well as in the microbial model, including the arylhydroxylamine (M1), the tert-butyl hydroxylated trantinterol (M2) and the 1-carbonyltrantinterol (M3). Another important pathway in rats is glutathione conjugation and further catabolism and oxidation to form consecutive derivatives (M4 through M10). Other metabolites include glucuronide, glucoside, and sulfate conjugates. The results of in vitro experiments indicate no species difference exists among rats, humans, and C. blakesleana AS 3.970 on the phase I metabolism of trantinterol. Our study provided the most comprehensive picture for trantinterol in vivo and in vitro metabolism to this day, and may predict its metabolism in humans.
Collapse
Affiliation(s)
- Kunjie Li
- Department of Analytical Chemistry, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China
| | | | | | | | | |
Collapse
|
6
|
Synthesis, structure characterization, and enzyme screening of clenbuterol glucuronides. Eur J Pharm Sci 2009; 37:581-7. [DOI: 10.1016/j.ejps.2009.05.003] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2009] [Revised: 04/21/2009] [Accepted: 05/06/2009] [Indexed: 11/22/2022]
|
7
|
Courant F, Pinel G, Bichon E, Monteau F, Antignac JP, Le Bizec B. Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves. Analyst 2009; 134:1637-46. [DOI: 10.1039/b901813a] [Citation(s) in RCA: 100] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
|
8
|
Pietraforte D, Brambilla G, Camerini S, Scorza G, Peri L, Loizzo A, Crescenzi M, Minetti M. Formation of an adduct by clenbuterol, a beta-adrenoceptor agonist drug, and serum albumin in human saliva at the acidic pH of the stomach: evidence for an aryl radical-based process. Free Radic Biol Med 2008; 45:124-35. [PMID: 18440320 DOI: 10.1016/j.freeradbiomed.2008.03.018] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/16/2007] [Revised: 03/20/2008] [Accepted: 03/22/2008] [Indexed: 11/19/2022]
Abstract
Clenbuterol (CLB) is an antiasthmatic drug used also illegally as a lean muscle mass enhancer in both humans and animals. CLB and amine-related drugs in general are nitrosatable, thus raising concerns regarding possible genotoxic/carcinogenic activity. Oral administration of CLB raises the issue of its possible transformation by salivary nitrite at the acidic pH of gastric juice. In acidic human saliva CLB was rapidly transformed to the CLB arenediazonium ion. This suggests a reaction of CLB with salivary nitrite, as confirmed in aerobic HNO(2) solution by a drastic decrease in nitric oxide, nitrite, and nitrate. In human saliva, both glutathione and ascorbic acid were able to inhibit CLB arenediazonium formation and to react with preformed CLB arenediazonium. The effect of ascorbic acid is particularly pertinent because this vitamin is actively concentrated within the gastric juice. EPR spin trapping experiments showed that preformed CLB arenediazonium ion was reduced to the aryl radical by ascorbic acid, glutathione, and serum albumin, the major protein of saliva. As demonstrated by anti-CLB antibodies and MS, the CLB-albumin interaction leads to the formation of a covalent drug-protein adduct, with a preference for Tyr-rich regions. This study highlights the possible hazards associated with the use/abuse of this drug.
Collapse
Affiliation(s)
- D Pietraforte
- Department of Cell Biology and Neurosciences, Istituto Superiore di Sanità, 00161 Roma, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
9
|
Kuffel MJ, Schroeder JC, Pobst LJ, Naylor S, Reid JM, Kaufmann SH, Ames MM. Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2. Mol Pharmacol 2002; 62:143-53. [PMID: 12065765 DOI: 10.1124/mol.62.1.143] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The present studies were performed to elucidate the mechanism of cytotoxicity of the aminoflavone analog (5-amino-2,3-fluorophenyl)-6,8-difluoro-7-methyl-4H-1-benzopyran-4-one (AF; NSC 686288), a novel flavone with potent in vitro and in vivo antiproliferative activity against a number of human tumor cell lines and with a unique pattern of antiproliferative activity in the National Cancer Institute tumor cell line screen. AF was extensively metabolized by cytochrome P450 (P450) 1A1 and 1A2 to several metabolites, one of which was identified by mass spectrometry as a potentially reactive hydroxylamine. Radiolabeled AF was converted by rat and human microsomes, by recombinant CYP1A1 and CYP1A2, and by sensitive human tumor cell lines to species that covalently bound macromolecules. Treatment of sensitive human MCF7 cells with AF resulted in increased CYP1A1 mRNA and CYP1A1/1A2 protein followed by covalent binding of an AF metabolite to DNA, phosphorylation and stabilization of p53, and increased expression of the p53 transcriptional target p21. Covalent binding of the AF metabolite was increased by pretreatment with the CYP1A inducer 3-methylcholanthrene and decreased by coincubation with the CYP1A inhibitor alpha-naphthoflavone. In contrast, induction of CYP1A1 and covalent binding of the AF metabolite did not occur in AF-resistant M14-MEL cells. These observations suggest that AF is uniquely able to induce its own metabolic activation via CYP1A1/1A2 in duction to cytotoxic DNA-damaging species directly in tumor cells. AF, and possibly other agents, may offer a treatment strategy for tumors responsive to CYP1A1/1A2 induction, such as breast, ovarian, and renal cancers.
Collapse
Affiliation(s)
- Mary J Kuffel
- Department of Oncology, Mayo Clinic, Rochester, Minnesota 55905, USA
| | | | | | | | | | | | | |
Collapse
|
10
|
Smith DJ. Stereochemical composition of clenbuterol residues in edible tissues of swine. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY 2000; 48:6036-6043. [PMID: 11312776 DOI: 10.1021/jf001054v] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
A gas chromatography-mass spectrometry method was developed to measure the stereochemical residues of clenbuterol derivatives in edible tissues of swine. Clenbuterol present in tissue extracts was derivatized with phosgene to form clenbuterol oxazolidin-3-one, which was then separated into component enantiomers using a dimethyl beta-cyclodextrin capillary gas chromatographic column. Purified clenbuterol stereoisomers, isolated using published liquid chromatographic techniques, were used to determine stereoisomer elution order, stereoisomer racemization potential, and accuracy of the method. The stereochemical composition of clenbuterol could be measured at tissue concentrations of <2 ppb using the method. The dextrorotatory stereoisomer was the predominant clenbuterol stereoisomer present in edible tissues of hogs slaughtered after withdrawal periods of 0, 3, and 7 days, with a (+)/(-) isomer ratio of about 3:1. The prevalence of the dextrorotatory stereoisomer in edible tissues of hogs at all withdrawal periods suggests that stereoselective processes are occurring during the absorption, distribution, metabolism, and (or) excretion of clenbuterol. The effect of clenbuterol dose on its stereochemical composition in edible tissues is unknown but will be an area of further investigation.
Collapse
Affiliation(s)
- D J Smith
- Biosciences Research Laboratory, Agricultural Research Service, U.S. Department of Agriculture, P.O. Box 5674, University Station, Fargo, North Dakota 58105, USA.
| |
Collapse
|
11
|
Abukhalaf IK, von Deutsch DA, Parks BA, Wineski L, Paulsen D, Aboul-Enein HY, Potter DE. Comparative analytical quantitation of clenbuterol in biological matrices using GC-MS and EIA. Biomed Chromatogr 2000; 14:99-105. [PMID: 10694703 DOI: 10.1002/(sici)1099-0801(200004)14:2<99::aid-bmc933>3.0.co;2-g] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
A simple and sensitive procedure utilizing GC-MS for the identification and quantitation of clenbuterol in biofluids and tissues is described. This improved method utilizes trimethylboroxine for the derivatization of clenbuterol, requires only 1 mL/g of biological sample, and most importantly does not require an extra cleaning step for urine specimens prior to extraction. Linear quantitative response curves have been generated for derivatized clenbuterol over a concentration range of 5-200 ng/mL. The extraction efficiency at four representative points of the standard curve exceeded 90% in both specimen types (plasma and urine). Linear regression analyses of the standard curve in both specimen types exhibited correlation coefficients ranging from 0.997 to 1.000. The Limit of detection (LOD) and Limit of quantitation (LOQ) values for plasma specimens were determined to be 0.5 and 1.5 ng/mL respectively. For urine specimens, LOD and LOQ values were 0.2 and 0.7 ng/microL respectively. Percentage recoveries ranged from 91 to 95% for urine and 89 to 101% for plasma. Precision and accuracy (within-run and between-run) studies reflected a high level of reliability and reproducibility of the method. In addition to its reliability, sensitivity and simplicity, this modified procedure is more efficient and cost effective, requiring less time, only 1 mL of sample, and minimal amounts of extraction solvents. The applicability of the method for the detection and quantitation of clenbuterol in biological tissues of rats treated with the drug was demonstrated successfully. For comparative analysis of clenbuterol in plasma and liver samples, both GC-MS and enzyme immunoassay (EIA) methods are found to be suitable. Due to potential antibody-cross reactivity with EIA, the GC-MS method is the method of choice for most samples because of its specificity. However, the EIA method is considered the method of choice for analysis of clenbuterol found in concentrations below the limits of quantitation by GC-MS due to its sensitivity.
Collapse
Affiliation(s)
- I K Abukhalaf
- Department of Pharmacology and Toxicology, Morehouse School of Medicine, Atlanta, GA 30310, USA
| | | | | | | | | | | | | |
Collapse
|
12
|
Bazylak G, Aboul-Enein HY. Supramolecular effects in chiral discrimination of clenbuterol enantiomers in RP-HPLC system with helically self-assembled mobile-phase additive. Retention studies and molecular modeling approach. Chirality 1999. [DOI: 10.1002/(sici)1520-636x(1999)11:5/6<387::aid-chir7>3.0.co;2-u] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|